SHIM
PHAR

Stone House Investment Management’s Pharming Group PHAR Stock Holding History

Stone House Investment Management’s Portfolio PHAR Stock Details PHAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-79
Closed -$1.31K – 1400
2026
Q1 		$1.31K Buy
+79
New +$1.34K ﹤0.01% 666

Other funds holding PHAR

MACM
MAC Alpha Capital Management Tampa, Florida $216M AUM
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
SGFG
Silver Grove Financial Group Orchard Park, New York $185M AUM 28.01% 1-Year Est. Return
NSG
Nalls Sherbakoff Group Knoxville, Tennessee $141M AUM 25.05% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM

Stone House Investment Management's PHAR Position: Q2 2026 in Review

Stone House Investment Management sold out of Pharming Group (PHAR) in Q2 2026, closing a stake of 79 shares — an estimated $1.31K sold.

Stone House Investment Management first reported a position in PHAR in Q1 2026 and held it in 1 quarter. The position peaked at $1.31K in Q1 2026. 17 funds tracked by Wall St. Rank hold PHAR as of Q2 2026.

  • Stone House Investment Management reported no remaining Pharming Group position as of Q2 2026 after selling out during the quarter.
  • Stone House Investment Management sold 79 Pharming Group shares in Q2 2026, an estimated $1.31K.
  • Stone House Investment Management first reported a position in Pharming Group in Q1 2026 and held it in 1 quarter.
  • Stone House Investment Management's Pharming Group position peaked at $1.31K in Q1 2026.
  • 17 funds tracked by Wall St. Rank held Pharming Group as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.